WANG W ET AL: "ANTIBODY STRUCTURE, INSTABILITY, AND FORMULATION" JOURNAL OF PHARMACEUTICAL SCIENCE,, vol. 96, no. 1, 1 January 2007 (2007-01-01), pages 1-26, XP009084505 ISSN: 0022-3549 (B1)

WO-A-2004/071439 (B1)

WO-A-95/19790 (B1)

DAUGHERTY ANN L ET AL: "Formulation and delivery issues for monoclonal antibody therapeutics" ADVANCED DRUG DELIVERY REVIEWS, vol. 58, no. 5-6, August 2006 (2006-08), pages 686-706, XP005611422 ISSN: 0169-409X (B1)

WAKANKAR ADITYA A ET AL: "The effect of cosolutes on the isomerization of aspartic acid residues and conformational stability in a monoclonal antibody" JOURNAL OF PHARMACEUTICAL SCIENCE,, vol. 96, no. 7, 1 July 2007 (2007-07-01), pages 1708-1718, XP009108930 ISSN: 0022-3549 (B1)

RUDIKOFF S ET AL: "Single amino acid substitution altering antigen-binding specificity" PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC.; US, vol. 79, 1 March 1982 (1982-03-01), pages 1979-1983, XP007901436 ISSN: 0027-8424 (B1)

SHIRE STEVEN J ET AL: "Challenges in the development of high protein concentration formulations" JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 93, no. 6, June 2004 (2004-06), pages 1390-1402, XP009108986 ISSN: 0022-3549 (B1)

VOLLMER T L ET AL: "An open-label safety and drug interaction study of natalizumab (Antegren(TM)) in combination with interferon-beta (Avonex(R)) in patients with multiple sclerosis" MULTIPLE SCLEROSIS, vol. 10, no. 5, 2004, pages 511-520, XP009109055 ISSN: 1352-4585 (B1)

HARRIS R J ET AL: "Commercial manufacturing scale formulation and analytical characterization of therapeutic recombinant antibodies" DRUG DEVELOPMENT RESEARCH, NEW YORK, NY, US, vol. 61, no. 3, 1 March 2004 (2004-03-01), pages 137-154, XP002324970 ISSN: 0272-4391 (B1)